pargyline has been researched along with Serotonin Syndrome in 2 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Serotonin Syndrome: An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boban Blagaic, A | 1 |
| Blagaic, V | 1 |
| Mirt, M | 1 |
| Jelovac, N | 1 |
| Dodig, G | 1 |
| Rucman, R | 1 |
| Petek, M | 1 |
| Turkovic, B | 1 |
| Anic, T | 1 |
| Dubovecak, M | 1 |
| Staresinic, M | 1 |
| Seiwerth, S | 1 |
| Sikiric, P | 1 |
| Izumi, T | 1 |
| Iwamoto, N | 1 |
| Kitaichi, Y | 1 |
| Kato, A | 1 |
| Inoue, T | 1 |
| Koyama, T | 1 |
2 other studies available for pargyline and Serotonin Syndrome
| Article | Year |
|---|---|
Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats.
Topics: Animals; Anti-Ulcer Agents; Antidepressive Agents, Second-Generation; Behavior, Animal; Body Tempera | 2005 |
Effects of co-administration of a selective serotonin reuptake inhibitor and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Brain; Clorgyline; Dose-Response Relationship, Drug | 2006 |